Pharmacy Question for the Week of May 1, 2017


According to the American Medical Association (AMA), the following code took effect on January 1, 2017: 90682—influenza virus vaccine, quadrivalent (RIV4), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use. However, our MAC has denied claims for this code. Does Medicare not accept this new code?


According to the Centers for Medicare & Medicaid Services (CMS), claims with dates of service (DOS) on or after July 1, 2017 will be paid for influenza virus code 90682. Contractors shall deny claims submitted with code 90682 for DOS between January 1, 2017 and June 30, 2017. For details of this policy, go to transmittal R3754CP at


CPT® copyright 2022 American Medical Association (AMA). All rights reserved.

Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

CPT is a registered trademark of the American Medical Association.